October 30th, 2019 LEO Pharma Enters into Option Agreement with Ubiquigent for Access to Novel Compounds
August 15th, 2018 Ubiquigent awarded Innovate UK grant, closes further round of investment and strengthens management team
April 5th, 2018 Ubiquigent and Forma Therapeutics enter an exclusive R&D collaboration to develop novel DUB inhibitors